prolongs repolarization in Purkinje fibers at concentrations 901 -908) in this issue.
receptor mRNA to be distributed non-uniformly throughalbeit indirectly, in the generation of the malignant venout the rat heart, with a1b receptor transcripts being most tricular arrhythmia torsade de pointes. One of the more common (.50%), except in papillary muscle and the consistent and predictive models of drug-induced torsade septal region, which contained a high proportion of a1a de pointes involves the pretreatment of rabbits with receptor message. In human ventricle, alpha-1-receptors methoxamine prior to administration of the test compound. are considered to be low in density and to mediate only In this model, IKr blockers such as dofetilide [19] , dweak second messenger (IP3) signals [11] .
sotalol [20] and almokalant [21] reliably generate QT Burashnikov and Antzelevitch [1] report that action prolongation followed by a polymorphic ventricular tachypotential duration is prolonged by alpha-1-agonists in cardia. This model has become one that is used by canine Purkinje fibers but shortened in canine M-cells.
pharmaceutical companies to assess the risk of serious These two effects appear to be mediated by different proarrhythmia for drugs that prolongs the QT interval. The receptor subtypes, as evidenced by the ability of the a1b results presented by Burashnikov and Antzelevitch [1] antagonist clorethylclonidine (CEC) to inhibit the shortraise several interesting points. First, the preferential ening in M-cells but not the prolongation in Purkinje prolongation by methoxamine of action potential duration fibers. Unfortunately, the data do not permit one to in Purkinje fibers versus M-cells suggest that the triggering associate these particular electrophysiological effects with event in the methoxamine-treated rabbit model may ina regional distribution of alpha-1-receptor subtypes in volve the Purkinje system. This is consistent with tridithese tissues. Nor can one draw clear conclusions about mensional mapping data placing the initiating event for which membrane currents mediate the effects on repolaritorsade at the subendocardial surface [22] . Moreover, the zation time course. Of interest in this regard is the finding data clearly establish that methoxamine pretreatment that the amount of alpha-1-agonist induced prolongation dramatically alters the electrical substrate of the heart, and decreases with increasing rates of stimulation, a phenomresets the baseline dispersion of ventricular refractoriness enon know in the antiarrhythmic drug literature as 'reverse so that it favors an arrhythmic response. This means that use-dependence.' This suggests that that target for alpha-1-the effects of QT-prolonging drugs such as dofetilide, a agonist action is a component of repolarization current potent and highly specific blocker of IKr, are not being whose role is minimized at short cycle lengths, e.g. the studied in isolation, but in a complex pharmacologic rapid delayed rectifier current IKr, which is consistent with setting that involves the non-specific and heterogeneous the conclusion reached by Lee and Rosen in their study of blockade of multiple potassium channel subtypes as backcanine Purkinje fibers [12] . The slow delayed rectifier IKs ground. From the standpoint of drug development in is enhanced by alpha-1-agonists [13] , and an offsetting predicting drug safety, one needs to evaluate whether these increase in this current may be the basis for the observed marked and perhaps non-physiological alterations in elecshortening of the M-cell action potential in the experiments trical substrate effectively capture the clinical conditions presented here. The data obtained by Burashnikov and under which serious pause-dependent arrhythmias are Antzelevitch [1] would suggest that the IKr effect is likely to become manifest. mediated via a1a receptors, while the IKs effect may depends on a1b receptor activation. The existing literature neither fully supports nor entirely refutes this interpreta-3. Limitations of the study tion, nor does it establish the basis for the differential effect. The authors suggest that cells with weak IKs (e.g.
The authors leave unresolved a most critical question: M-cells) may be more likely to have that current enhanced why do the effects of alpha-1-agonists differ in Purkinje by alpha-1-receptor stimulation than cells with a robust fibers and M-cells? Except for a pacemaker current and IKs. Whether a robust IKs is characteristic of Purkinje T-type calcium channels in Purkinje fibers, both appear to fibers is still unclear. More work is needed at both the contain the same complement of electrogenic cell commolecular and cellular levels to resolve these questions.
ponents, and, until now, both have been essentially indistinguishable in their response to drugs. Burashnikov and Antzelevitch cite the possibility that the level of IKs may 2. Clinical implications: alpha-1-receptors and be critical in determining the magnitude of the change arrhythmogenesis induced by alpha-1-agonists. The implications are that IKs is weak in M-cells and strong in Purkinje fibers, and that a There is a considerable body of work on alpha-1-recontribution of IKs can completely reverse the effect of ceptors and reperfusion arrhythmias [14, 15] , much of reduced IKr on repolarization time course. Neither is which links arrhythmogenesis to a1a receptor activation known at this time. Another possibility is that the type of [4, 16, 17] . However, specific blockers of a1a receptors alpha-1-receptors present on the surface of the two cells such as UK 52,046 fail to protect against induction of differ, or that there are differences in the post-receptor experimental arrhythmias in acutely ischemic myocardium signaling pathways and / or the effector sites involved. [18] . Alpha-1-receptor activation has also been implicated, However, a third possibility is that native alpha-receptor tions from within the myocardial wall represents an crucial insight that will enhance our understanding of how 
